News | December 13, 2022
US Federal Court dismisses cancer linkage associated with Zantac
The current ruling will assure the safety of the use of Ranitidine for Indian patients
The current ruling will assure the safety of the use of Ranitidine for Indian patients
Sitagliptin is an active ingredient in JANUVIA, JANUMET and JANUMET XR
NATCO is the first company in India to have received its registration approval given by Central Insecticide Board & Registration Committee (CIB&RC) for indigenous manufacture of Chlorantraniliprole
In 2018 NATCO and Alvogen had filed an Abbreviated New Drug Application (ANDA) with PIV certification for the generic version of the product
Jubilant successfully challenged Bracco's patent infringement claims in an Inter Parties Review (IPR) proceeding before the U.S. Patent Office
Parliament clears reform bill replacing jail terms for procedural lapses with graded monetary penalties across key health laws
Moderna will appeal to the Federal Circuit to assert that its government-contractor immunity limits liability under federal law
N17350 is the company’s first-in-class tumor-directed therapeutic, designed to harness the ELANE pathway
Vanda strongly disputes the FDA’s reasoning
While Merck can appeal, Halozyme said it expects the order to hold
Subscribe To Our Newsletter & Stay Updated
